U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284277) titled 'TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)' on Nov. 14.
Brief Summary: The purpose of this clinical trial is to assess the safety and tolerability of TTFields in combination with chemotherapy in adults with metastatic pancreatic adenocarcinoma based on treatment-emergent adverse events of chemotherapy (modFOLFIRINOX) or device (TTFields).
The main questions it aims to answer are:
* Is TTFields treatment safe for the patients in combination with modFOLFIRINOX?
* Are participants compliant with the treatment?
* Is Is TTFields treatment effective in combination with modFOLFIRINOX against metastatic pa...